745576
Last Update Posted: 2010-02-08
Recruiting has ended
All Genders accepted | 18 Years-55 Years |
14 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered
The purpose of this study is to evaluate the effects of multiple doses of verapamil on the plasma concentration of a single dose of SAM-531 in healthy young adult subjects and to assess the safety and tolerability of co-administration of SAM-531 and verapamil.
Eligibility
Relevant conditions:
Alzheimer Disease
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov